These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25843296)

  • 21. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
    Kurlawalla-Martinez C; Stiles B; Wang Y; Devaskar SU; Kahn BB; Wu H
    Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.
    Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Warnakulasuriya S; Lopes C
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):638-45. PubMed ID: 23601218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The attraction of lipids.
    Tromans A
    Nature; 2002 Jun; 417(6890):702. PubMed ID: 12066170
    [No Abstract]   [Full Text] [Related]  

  • 26. Functional definition of relevant epitopes on the tumor suppressor PTEN protein.
    Andrés-Pons A; Valiente M; Torres J; Gil A; Roglá I; Ripoll F; Cervera J; Pulido R
    Cancer Lett; 2005 Jun; 223(2):303-12. PubMed ID: 15896465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatase and tensin homologue growth suppression without phosphatase.
    Stokoe D; Costello JF
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2677-8. PubMed ID: 15710873
    [No Abstract]   [Full Text] [Related]  

  • 29. PTEN function: how normal cells control it and tumour cells lose it.
    Leslie NR; Downes CP
    Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor.
    Okumura K; Zhao M; Depinho RA; Furnari FB; Cavenee WK
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2703-6. PubMed ID: 15659546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
    Paez J; Sellers WR
    Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma].
    Wan XY; Shi YF; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):275-8. PubMed ID: 15312361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTENless means more.
    Stiles B; Groszer M; Wang S; Jiao J; Wu H
    Dev Biol; 2004 Sep; 273(2):175-84. PubMed ID: 15328005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
    Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
    Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biology and clinical relevance of the PTEN tumor suppressor pathway.
    Sansal I; Sellers WR
    J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
    Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D
    Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
    Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
    Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.
    Vella V; Puppin C; Damante G; Vigneri R; Sanfilippo M; Vigneri P; Tell G; Frasca F
    Int J Cancer; 2009 Jun; 124(11):2539-48. PubMed ID: 19173293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.